09 June 2000
Ann Transplant 2000; 5(2): 50-60 :: ID: 497526
Identification of immune parameters that predict longterm graft outcome would aid in identifying those recipients at low versus high risk for immune complications and chronic rejection. Those recpients at low risk presumably could have their immunosuppression successfully lowered or even weaned thereby avoiding the many side effects of immunosuppressive therapy. Recipients who are at high risk for chronic rejection may benefit from changing or even increasing the immunosuppressive therapy. This article focuses on using cellular assays to monitor changes, quantitative and qualitative, in the T-cell recognition process during the posttransplant period, as a means to predict long-term graft outcome. We have focused our studies on the cellular immune parameter of donor antigen-specific hyporeactivity to determine whether we can predict long-term graft outcome for all solid organ recipients [1-8]...
Keywords: MLC, chronic rejection, donor-specific non-responsivness, limiting dilution
Most Viewed Current Articles
26 Jan 2022 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
24 Aug 2021 : Review articleNormothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588